Cue Biopharma, Inc. (CUE)
25.52
-2.36
(-8.46%)
USD |
NASDAQ |
Aug 31, 16:00
25.70
+0.18
(+0.71%)
After-Hours: 20:00
Cue Biopharma Cash from Operations (TTM) : -50.05M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -50.05M |
| March 31, 2026 | -24.46M |
| December 31, 2025 | -21.69M |
| September 30, 2025 | -29.64M |
| June 30, 2025 | -28.14M |
| March 31, 2025 | -34.72M |
| December 31, 2024 | -36.33M |
| September 30, 2024 | -38.26M |
| June 30, 2024 | -38.53M |
| March 31, 2024 | -38.91M |
| December 31, 2023 | -39.96M |
| September 30, 2023 | -39.52M |
| June 30, 2023 | -38.59M |
| March 31, 2023 | -41.07M |
| December 31, 2022 | -41.81M |
| September 30, 2022 | -41.94M |
| Date | Value |
|---|---|
| June 30, 2022 | -41.69M |
| March 31, 2022 | -38.62M |
| December 31, 2021 | -38.84M |
| September 30, 2021 | -35.19M |
| June 30, 2021 | -36.25M |
| March 31, 2021 | -33.34M |
| December 31, 2020 | -32.49M |
| September 30, 2020 | -31.93M |
| June 30, 2020 | -33.45M |
| March 31, 2020 | -33.27M |
| December 31, 2019 | -30.80M |
| September 30, 2019 | -28.26M |
| June 30, 2019 | -25.35M |
| March 31, 2019 | -25.13M |
| December 31, 2018 | -26.41M |
| September 30, 2018 | -24.41M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 185.56M |
| Fortress Biotech, Inc. | 120.36M |
| Equillium, Inc. | -19.97M |
| Legend Biotech Corp. | -182.95M |
| Nurix Therapeutics, Inc. | -293.70M |